NCT03582007View on ClinicalTrials.gov

Pivotal Study in Nosocomial Pneumonia Suspected or Confirmed to be Due to Pseudomonas

PHASE3TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

October 22, 2018

Primary Completion Date

July 17, 2019

Study Completion Date

July 17, 2019

Conditions
Pneumonia
Interventions
DRUG

Murepavadin

Murepavadin + ertapenem

DRUG

One anti-pseudomonal antibiotic

Either meropenem or piperacillin-tazobactam

Trial Locations (7)

15213

Research Site, Pittsburgh

52242

Research site, Iowa City

Unknown

Research site, Břeclav

Research site, Kolín

Research site, Argenteuil

Research site, Hadera

Research site, Tel Aviv

Sponsors

Lead Sponsor

Polyphor Ltd.
All Listed Sponsors
lead

Polyphor Ltd.

INDUSTRY